Quantitative comparison of functional screening by measuring intracellular Ca(2+) with radioligand binding at recombinant human dopamine receptors

par Kassack, Matthias U.
Publié 2002

Ellagic Acid and Resveratrol Prevent the Development of Cisplatin Resistance in the Epithelial Ovarian Cancer Cell Line A2780

par Engelke, Laura H., Hamacher, Alexandra, Proksch, Peter, Kassack, Matthias U.
Publié dans J Cancer (2016)

Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38

par Gohr, Katharina, Hamacher, Alexandra, Engelke, Laura H., Kassack, Matthias U.
Publié dans BMC Cancer (2017)

Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676

par Wolner, Ilse, Kassack, Matthias U, Ullmann, Heiko, Karel, Anton, Hohenegger, Martin
Publié 2005

Adenosine enhances cisplatin sensitivity in human ovarian cancer cells

par Sureechatchaiyan, Parichat, Hamacher, Alexandra, Brockmann, Nicole, Stork, Bjoern, Kassack, Matthias U.
Publié dans Purinergic Signal (2018)

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines

par Bandolik, Jan J., Hamacher, Alexandra, Schrenk, Christian, Weishaupt, Robin, Kassack, Matthias U.
Publié dans Int J Mol Sci (2019)

Dibenzazecine compounds with a novel dopamine/5HT(2A )receptor profile and 3D-QSAR analysis

par Hamacher, Alexandra, Weigt, Mathias, Wiese, Michael, Hoefgen, Barbara, Lehmann, Jochen, Kassack, Matthias U
Publié 2006

Molecular modeling of G-protein coupled receptor kinase 2: Docking and biochemical evaluation of inhibitors

par Kassack, Matthias U., Högger, Petra, Gschwend, Daniel A., Kameyama, Kimihiko, Haga, Tatsuya, Graul, Richard C., Sadée, Wolfgang
Publié 2000

Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y(2) receptor antagonist

par Brockmann, Nicole, Sureechatchaiyan, Parichat, Müller, David, Hennicke, Tatiana, Hausmann, Ralf, Fritz, Gerhard, Hamacher, Alexandra, Kassack, Matthias U.
Publié dans Purinergic Signal (2019)

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

par Rodrigues Moita, Ana J., Bandolik, Jan J., Hansen, Finn K., Kurz, Thomas, Hamacher, Alexandra, Kassack, Matthias U.
Publié dans Int J Mol Sci (2020)

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1

par Wang, Chenyin, Hamacher, Alexandra, Petzsch, Patrick, Köhrer, Karl, Niegisch, Günter, Hoffmann, Michèle J., Schulz, Wolfgang A., Kassack, Matthias U.
Publié dans Cancers (Basel) (2020)

New Acetophenones and Chromenes from the Leaves of Melicope barbigera A. Gray

par Le, Kim-Thao, Bandolik, Jan J., Kassack, Matthias U., Wood, Kenneth R., Paetzold, Claudia, Appelhans, Marc S., Passreiter, Claus M.
Publié dans Molecules (2021)

Cryptic Secondary Metabolites from the Sponge-Associated Fungus Aspergillus ochraceus

par Frank, Marian, Özkaya, Ferhat Can, Müller, Werner E. G., Hamacher, Alexandra, Kassack, Matthias U., Lin, Wenhan, Liu, Zhen, Proksch, Peter
Publié dans Mar Drugs (2019)

Multicomponent synthesis and binding mode of imidazo[1,2-a]pyridine-capped selective HDAC6 inhibitors

par Mackwitz, Marcel K. W., Hamacher, Alexandra, Osko, Jeremy D., Held, Jana, Schöler, Andrea, Christianson, David W., Kassack, Matthias U., Hansen, Finn K.
Publié dans Org Lett (2018)

3-O-Methyl-Alkylgallates Inhibit Fatty Acid Desaturation in Mycobacterium tuberculosis

par Rehberg, Nidja, Omeje, Edwin, Ebada, Sherif S., van Geelen, Lasse, Liu, Zhen, Sureechatchayan, Parichat, Kassack, Matthias U., Ioerger, Thomas R., Proksch, Peter, Kalscheuer, Rainer
Publié dans Antimicrob Agents Chemother (2019)

Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y(11) receptor

par Vaughan, Kathryn R., Stokes, Leanne, Prince, Lynne R., Meis, Sabine, Kassack, Matthias U., Bingle, Colin D., Sabroe, Ian, Surprenant, Annmarie, Whyte, Moira K.B.
Publié 2007

Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells

par Eckstein, Niels, Servan, Kati, Girard, Luc, Cai, Di, von Jonquieres, Georg, Jaehde, Ulrich, Kassack, Matthias U., Gazdar, Adi F., Minna, John D., Royer, Hans-Dieter
Publié 2007

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)

par Sinatra, Laura, Bandolik, Jan J., Roatsch, Martin, Sönnichsen, Melf, Schoeder, Clara T., Hamacher, Alexandra, Schöler, Andrea, Borkhardt, Arndt, Meiler, Jens, Bhatia, Sanil, Kassack, Matthias U., Hansen, Finn K.
Publié dans Angew Chem Int Ed Engl (2020)

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)

par Friedrich, Annabelle, Assmann, Ann-Sophie, Schumacher, Lena, Stuijvenberg, Jana v., Kassack, Matthias U., Schulz, Wolfgang A., Roos, Wynand P., Hansen, Finn K., Pflieger, Marc, Kurz, Thomas, Fritz, Gerhard
Publié dans Int J Mol Sci (2020)

Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia Activity

par Pflieger, Marc, Sönnichsen, Melf, Horstick‐Muche, Nadine, Yang, Jing, Schliehe‐Diecks, Julian, Schöler, Andrea, Borkhardt, Arndt, Hamacher, Alexandra, Kassack, Matthias U., Hansen, Finn K., Bhatia, Sanil, Kurz, Thomas
Publié dans ChemMedChem (2021)